Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung CancerJoachim von Pawel, Richard J. Gralla, J P Kleisbauer et al.|Journal of Clinical Oncology|1999Cited by 960
Phase III Study of Oral Compared With Intravenous Topotecan As Second-Line Therapy in Small-Cell Lung CancerJohn R. Eckardt, Graham Ross, Joachim von Pawel et al.|Journal of Clinical Oncology|2007Cited by 384